Bristol Myers Squibb News and Resources

Bristol Myers Squibb has partnered with Scenic Biotech to access their Cell-Seq technology platform. This collaboration aims to unlock the underlying genetic interactions of cellular pathways for undisclosed targets. Scenic Biotech, a pioneer in the field of modifier therapies for